Opp - a Universal Mental Health Promoting Mobile Application for Adolescents (Opp)

December 8, 2023 updated by: University of Tromso

Opp: The Development and Evaluation of a Mental Health App for Adolescents

The aim of the project is firstly, to develop an app-based mental health intervention for adolescents. Secondly, to evaluate the effect of this app. The overarching goal is to offer a low-threshold intervention, called Opp, that is easily accessible and free to use for all adolescents in Norway.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

The intervention "Opp" will be delivered through a mobile application. The overall goals of Opp are to 1) increase well-being and mental well-being, 2) increase knowledge about mental health, 3) increase coping skills to deal with stress, 4) increase help-seeking behavior, 5) increase self-esteem, 6) increase sleep quality and 7) reduce mental health problems.

To evaluate the mobile application two studies will be conducted: A user survey and an effectiveness study with a follow-up examination after about six weeks. The effectiveness study will be conducted as a randomized controlled trial with an intervention group and a waiting-list control group.

Study Type

Interventional

Enrollment (Estimated)

700

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Tromsø, Norway
        • UiT The Arctic University of Norway

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adolescents under 16 years whose guardians have given consent

Exclusion Criteria:

  • severe developmental or cognitive challenges

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
The waiting list control group will receive the intervention after study completion.
Experimental: Intervention group receiving Opp
The effectiveness study will be conducted as a randomized controlled trial with an intervention group and a waiting-list control group. Data will be collected at baseline (T1, pre intervention) and after about six weeks of intervention (T2, post intervention).
Opp is a universal mental health promoting mobile application for adolescents aged 13-25 years.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in WHO-5 (WHO-Five Well-being Index)
Time Frame: Change from baseline to six weeks after intervention.
WHO-5 (WHO, 1998): A five item self-report questionnaire assessing well-being on a six point scale.
Change from baseline to six weeks after intervention.
Change in SDQ (Strengths and Difficulties Questionnaire)
Time Frame: Change from baseline to six weeks after intervention.
SDQ (Goodman, 1997): A 25 item self-report assessing mental health and psychosocial functioning in 11-17 years old adolescents on a three point scale.
Change from baseline to six weeks after intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General Self-efficacy scale (GSE)
Time Frame: Change from baseline to six weeks after intervention.
Resilience will be measured with the Norwegian version of the GSE (Røysamb, 1997; Schwarzer et al., 1995) which consists of 10 questions measured on a four-point scale.
Change from baseline to six weeks after intervention.
Help-seeking behavior
Time Frame: Change from baseline to six weeks after intervention.
Two self-report items measuring if they sought help and who they sought help from.
Change from baseline to six weeks after intervention.
Self-liking and Competence Scale
Time Frame: Change from baseline to six weeks after intervention.
Self-liking and Competence Scale (Silvera, Neilands, & Perry, 2001; Tafarodi & Swann, 2001): A 20 item self-report assessing self-liking and self-competence.
Change from baseline to six weeks after intervention.
Sleeping quality
Time Frame: Change from baseline to six weeks after intervention.
Sleeping quality will be measured with six questions from the Bergen Child Study (Hysing, Harvey, Stormark, Pallesen, & Sivertsen, 2018).
Change from baseline to six weeks after intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Henriette Kyrrestad, PhD, UiT The Arctic University of Norway

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

November 15, 2023

Study Completion (Estimated)

December 1, 2030

Study Registration Dates

First Submitted

December 15, 2021

First Submitted That Met QC Criteria

January 13, 2022

First Posted (Actual)

January 27, 2022

Study Record Updates

Last Update Posted (Actual)

December 15, 2023

Last Update Submitted That Met QC Criteria

December 8, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 279207

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Wellness 1

Clinical Trials on Opp

3
Subscribe